Biovica establishes experienced US sales team

2022-12-01 14:40:00

Biovica, active in cancer diagnostics, today announces that the company has employed a sales team of total of eight people to secure a fast and smooth launch and the further commercial development of DiviTum® TKa on the US market.

Biovica’s US organization is growing in preparation to the upcoming launch of the blood-based test DiviTum® TKa, that was recently cleared by the FDA. Biovica plans to launch DiviTum®TKa on the US market, through the fully owned laboratory in San Diego before the end of 2022. All team members have a long and successful background within diagnostics sales and collectively have more than 130 years of experience and a history of being top performers.

The team consists of the following roles.

  • Four specialty sales representatives have been hired to drive engagement with health care professionals in face-to-face meetings and to educate on DiviTum® TKa’s strong clinical data. Their expertise will simplify ordering and samples collection logistics. They will help minimize patient out-of-pocket expense through direct bill and financial assistance programs.
  • In addition to the specialty sales representatives, Biovica has hired two market access directors who will leverage their relationships with hospitals to execute direct bill contracts. They will also partner with Integrated Delivery Networks (IDNs) and drive inclusion into care pathways. These market access directors will have a regional payer focus.
  • To their help, specialty sales representatives and market access directors will have a Head of managed care and a Head of revenue cycle to drive and support execution.

“I am extremely pleased that these high performing industry professionals have committed to join our growing Biovica team. As a patient-centric organization, I am confident that we now have a very strong core team in place to successfully bring DiviTum®TKa to patients and their healthcare providers nationwide” said Warren Cresswell, Biovica President of the Americas.

MFN